Journal of affective disorders · 2025
Treatment resistant depression: Socio-demographic characteristics, comorbidity and treatment patterns from the All of Us Research Program.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Forthman Katherine L, Kuplicki Rayus, Thompson Wesley K, Nemeroff Charles B, Si Yajuan, Fan Chun Chieh, Paulus Martin P
Аннотация
OBJECTIVE: This study used the All of Us (AoU) cohort to investigate treatment-resistant depression (TRD) and its demographic associations, comorbidities and antidepressant treatment patterns.
METHODS: Electronic health records were used to classify major depressive disorder participants as treatment resistant. Logistic regressions determined socio-demographic and comorbidity differences between participants with TRD and treatment-responsive depression. Sankey diagrams visualized differences in treatment patterns.
RESULTS: 13.92 % of the depression population was characterized as TRD. The TRD population was 19.10 % of the medicated depression population. Compared to treatment-responsive depression individuals, those with TRD had lower education (Odds Ratio (OR) = 1.10 [1.03, 1.16]), were unemployed (OR = 1.35 [1.27, 1.43]) or in lower income brackets (OR < 35 k = 1.10 [1.03, 1.18]), and were more likely to be between ages 35-44 (OR = 1.15 [1.07, 1.24]). TRD relative to treatment-responsive depression individuals were more likely to have comorbidity with anxiety disorders (ORs ranging from 1.85 to 2.56 for various forms), Post-Traumatic Stress Disorder (OR = 2.10) and substance use disorders (ORs from 1.36 to 3.12). A Sankey diagram revealed heterogeneity in treatment among TRD and treatment-responsive depression.
CONCLUSION: This study finds that TRD is especially prevalent among younger individuals, those with lower income, the unemployed, and individuals with comorbid anxiety or substance use disorders. This underscores the importance of integrating socio-demographic and clinical characteristics into targeted strategies aimed at identifying high-risk populations and guiding more effective treatment approaches.
METHODS: Electronic health records were used to classify major depressive disorder participants as treatment resistant. Logistic regressions determined socio-demographic and comorbidity differences between participants with TRD and treatment-responsive depression. Sankey diagrams visualized differences in treatment patterns.
RESULTS: 13.92 % of the depression population was characterized as TRD. The TRD population was 19.10 % of the medicated depression population. Compared to treatment-responsive depression individuals, those with TRD had lower education (Odds Ratio (OR) = 1.10 [1.03, 1.16]), were unemployed (OR = 1.35 [1.27, 1.43]) or in lower income brackets (OR < 35 k = 1.10 [1.03, 1.18]), and were more likely to be between ages 35-44 (OR = 1.15 [1.07, 1.24]). TRD relative to treatment-responsive depression individuals were more likely to have comorbidity with anxiety disorders (ORs ranging from 1.85 to 2.56 for various forms), Post-Traumatic Stress Disorder (OR = 2.10) and substance use disorders (ORs from 1.36 to 3.12). A Sankey diagram revealed heterogeneity in treatment among TRD and treatment-responsive depression.
CONCLUSION: This study finds that TRD is especially prevalent among younger individuals, those with lower income, the unemployed, and individuals with comorbid anxiety or substance use disorders. This underscores the importance of integrating socio-demographic and clinical characteristics into targeted strategies aimed at identifying high-risk populations and guiding more effective treatment approaches.